Nuvation Bio Inc. (NUVB) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$213.06M | +64.0% |
| 2024 | -$592.63M | -493.7% |
| 2023 | -$99.82M | +16.6% |
| 2022 | -$119.73M | -28.3% |
| 2021 | -$93.32M | -114.3% |
| 2020 | -$43.55M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$213.06M | +64.0% |
| 2024 | -$592.63M | -493.7% |
| 2023 | -$99.82M | +16.6% |
| 2022 | -$119.73M | -28.3% |
| 2021 | -$93.32M | -114.3% |
| 2020 | -$43.55M | — |